SUMMIT OXFORD LTD has a total of 21 patent applications. It decreased the IP activity by 50.0%. Its first patent ever was published in 2009. It filed its patents most often in United Kingdom, Australia and Brazil. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are CHEMGENEX THERAPEUTICS INC, NEUROGENETIC PHARMACEUTICALS INC and ST IP HOLDING AG.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 7 | |
#2 | Australia | 3 | |
#3 | Brazil | 3 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Philippines | 1 | |
#10 | United States | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Horne Graeme | 6 |
#2 | Wilson Francis Xavier | 3 |
#3 | Graeme Horne | 3 |
#4 | Francis Xavier Wilson | 2 |
#5 | Johnson Peter David | 2 |
#6 | Dorgan Colin Richard | 2 |
#7 | Colin Richard Dorgan | 2 |
#8 | Vickers Richard | 2 |
#9 | Richard Vickers | 2 |
#10 | Alan Geoffrey Roach | 1 |
Publication | Filing date | Title |
---|---|---|
GB202100470D0 | Solid tablet dosage for of ridinilazole | |
GB202100471D0 | Preparation of antibacterial compounds | |
WO2021009514A1 | Process for the preparation of ridinilazole and crystalline forms thereof | |
GB201912144D0 | Antibacterial compounds | |
GB201910250D0 | Preparation of antibacterial compounds | |
GB201907732D0 | Preparation of antibacterial compounds | |
EP3500245A1 | Composition for the treatment of duchenne muscular dystrophy | |
GB201119533D0 | Compounds for the treatment of neoplasia | |
GB201019110D0 | Compounds for the treatment of neoplasia |